Global Pharmaceuticals & Biotech Breakout Stocks

Akeso

Market Cap: HK$77.1b

A biopharmaceutical company, researches, develops, manufactures, and commercializes antibody drugs.

Corcept Therapeutics

Market Cap: US$8.8b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

ApicHope Pharmaceutical Group

Market Cap: CN¥13.5b

Engages in the research and development, production, and sale of pharmaceutical drugs.

Peptron

Market Cap: ₩2.5t

Engages in the development of peptide-based medicines.

Zhuhai Rundu Pharmaceutical

Market Cap: CN¥6.5b

Develops, produces, and markets pharmaceutical ingredients for cardiovascular, gastrointestinal, and CNS worldwide.

Lepu Biopharma

Market Cap: HK$6.8b

A biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for cancer targeted therapy and immunotherapy in China and internationally.

Hvsen Biotechnology

Market Cap: CN¥5.8b

Engages in the research and development, and manufacture of macrolides APIs and preparations in China and internationally.

Hinova Pharmaceuticals

Market Cap: CN¥4.2b

A clinical-stage pharmaceutical company, engages in the development and production of therapeutics for cancers and metabolic syndromes.

Harbin Medisan Pharmaceutical

Market Cap: CN¥4.1b

Engages in the research, development, production, and sale of pharmaceutical product and medical devices in China.

ChengDa Pharmaceuticals

Market Cap: CN¥3.7b

Engages in the research and development, production, and sale of pharmaceutical intermediates, chemical ingredients, and food and feed additives in China and internationally.

Tibet Duo Rui Pharmaceutical

Market Cap: CN¥2.6b

Engages in the research and development, production, and sale of chemical pharmaceutical preparations and its raw materials in China.

Essex Bio-Technology

Market Cap: HK$2.7b

An investment holding company, develops, manufactures, distributes, and sells bio-pharmaceutical products in the People’s Republic of China, Hong Kong, and internationally.

DT&CRO

Market Cap: ₩72.6b

Operates as a full-service CRO provider in South Korea.

Zenith Drugs

Market Cap: ₹1.7b

Operates as a pharmaceutical manufacturing and trading company in India and internationally.

Pharmesis International

Market Cap: S$19.2m

An investment holding company, research, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People’s Republic of China.

Elicera Therapeutics

Market Cap: SEK 103.5m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

Can B

Market Cap: US$7.7m

Develops, manufactures, and sells hemp biomass derived products containing cannabinoids.

AccuStem Sciences

Market Cap: US$6.2m

A clinical stage diagnostics company, focuses on developing and commercializing products for the treatment and management of various cancers.

Vilin Bio Med

Market Cap: ₹373.9m

Engages in the manufacture and sale of pharmaceutical products in India.

Aoxing Pharmaceutical Company

Market Cap: US$2.7m

A specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People’s Republic of China.

RespireRx Pharmaceuticals

Market Cap: US$2.2m

Engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders.

Itoco

Market Cap: US$2.1m

Engages in the processing, production, and distribution of medical cannabis products.

Psyence Group

Market Cap: CA$2.8m

A life science biotechnology company, engages in the cultivation and production of commercial psilocybin mushroom.

Nouveau Life Pharmaceuticals

Market Cap: US$1.3m

A development stage company, engages in the development of nutraceuticals products.

Plandaí Biotechnology

Market Cap: US$888.9k

Focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries.

Vitalibis

Market Cap: US$622.6k

Operates as a technology-based formulator of phytocannabinoid rich hemp products with cannabidiol, along with personal care and nutritional products.

Molecular Pharmacology (USA)

Market Cap: US$399.8k

Molecular Pharmacology (USA) Limited, a development stage company, develops and commercializes pain and inflammation management products primarily in Australia and the United States.

Affymax

Market Cap: US$178.8k

Does not have significant operations.

Flower One Holdings

Market Cap: US$4.7k

Engages in the cultivation and production of medical and recreational cannabis.